Table 1

Demographic and clinicopathologic characteristics of 152 subjects comprising IHC study cohort
IHC cohort
BCa (%) n = 142 Controls (%) n = 10
Median age (range, y) 73 (30–94) 29 (15–48)
Median age (range, y) 73 (30–94) 29 (15–48)
Race
  Caucasian 134 (94%) N/A
  African American 5 (4%) N/A
  Other 3 (2%) N/A
Median follow-up (months) 13 11
Clinical stage
  Tis 16 (11%)
  Ta 6 (4%)
  T1 60 (42%)
  ≥T2 60 (42%)
Tumor grade
  Low 11 (8%)
  High 131 (92%)

Abbreviations: IHC immunohistochemistry, BCa bladder cancer, N/A not available.

Miyake et al.

Miyake et al. BMC Cancer 2013 13:322   doi:10.1186/1471-2407-13-322

Open Data